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for the SF-12 were 52.7 for the physical dimension (PD) and 40.7 for the mental 
dimension (MD). The average score obtained on the BISS scale is 22.64 and a ques-
tionnaire to assess the perceived stress indicates a stress level of 19.01. At 14 days,
the decrease in waistline was 1.66 cm (p  0.001) and the symptoms score was 91 
(p  0.05). With regards to the scales dealing with QoL, average scores at D14 for
SF-12 were 53 for PD and 43.4 for MD. Improvement of the mental dimension (p 
0.02). Average score obtained on the BISS scale is 26.34 (p  0.01) Perceived stress
level was 17.9 (p  0.003). CONCLUSIONS: At the end of the 14 days, the reduction
in waist circumference is statistically signiﬁ cant. We also noted an improvement in the 
overall symptoms score; an improvement that has been conﬁ rmed by an improvement 
of all symptoms.
HEALTH CARE INTERVENTIONS – Clinical Outcomes Studies
PHC1
COMPARATIVE EFFECTIVENESS OF LOW INTENSITY PULSED
ULTRASOUND VERSUS SHAM TREATMENT OF TIBIA FRACTURE
IN PATIENTS WITH NONUNION: A DOUBLE-BLIND, MULTI-CENTER
RANDOMIZED CONTROLLED TRIAL
Schofer M1, Schmelz A2, Schultz M3
1University Hospital Giessen and Marburg, Marburg, Germany, 2University of Ulm, Ulm, 
Germany, 3Pharmaccess Inc, Westmount, QC, Canada
OBJECTIVES: Treatment with LIPUS results in greater increases in bone density and 
greater reductions in bone gap area as compared to sham control in tibia fractures 
with NU(no progression of healing for at least four months). Fractures that do not 
heal after several months represent signiﬁ cant clinical and economic burden to health
care systems. Five to ten percent of all fractures are eventually classiﬁ ed as
nonunions[NU], fractures that fail to heal or will not heal without intervention.
Interventions include treatment by cast/brace, surgery, electrical stimulation, or low-
intensity pulsed ultrasound[LIPUS]. METHODS: Two primary effectiveness variables, 
change of bone density and gap area during treatment, were selected as surrogates for
bone healing. Abbreviated treatment period was maximum that sham treatment could 
be administered ethically. Both variables measured by blinded central reviewers from
CT-scans taken before/after termination of treatment. All adverse events recorded,
evaluated. Treatment duration was 16 weeks. Patients instructed to apply device once
daily for 20 minutes. Control (sham) devices were visually identical but did not
transmit ultrasound waves. Neither patients nor physicians could recognize shams.
RESULTS: A total of 101 patients enrolled (51 LIPUS, 50 sham), mean age 42.6 
(active) versus 45.1 years (sham). Based on log-transformed data, mean improvement 
in bone density was 1.34 (90% CI 1.14 to 1.57) times greater for patients randomized
to LIPUS compared to sham (p  0.002). A mean reduction in bone gap area also 
favored LIPUS treatment (p  0.014). CONCLUSIONS: Double-blind, intent-to-treat 
analyses demonstrated statistically signiﬁ cant superior effectiveness for LIPUS device 
compared to sham in terms of both endpoints over 16 weeks of treatment. Estimated
increase in bone density among patients randomized to LIPUS treatment was 34% 
greater than among patients randomized to sham. A signiﬁ cantly greater mean reduc-
tion in bone gap area after LIPUS treatment was also shown. Evaluation of adverse 
events showed that ultrasound therapy is safe.
HEALTH CARE INTERVENTIONS – Cost Studies
PHC2
SOCIOECONOMIC STATUS AND COST OF CARE IN THE ELDERLY
UNDERGOING MAJOR ORTHOPEDIC SURGERY
Baser O1, Wang L2, Gust C2, Dysinger A2
1University of Michigan and STATinMED Research, Ann Arbor, MI, USA, 2STATinMED
Research, Ann Arbor, MI, USA
OBJECTIVES: Socioeconomic status is associated with patients’ health behaviors,
health problems as well as the quality of care they receive. We examined data on U.
S. elderly patients undergoing major orthopedic surgery to determine whether socio-
economic status was associated with cost of care for patients with similar access to 
health care provided by Medicare. METHODS: We used the 2004–2006 Medicare 
data to identify all patients undergoing major orthopedic surgery. We used previously 
constructed and validated SESScore ™, which is a summary measure of socioeconomic 
status for each U.S. zip code, using data from the 2000 U.S. Census. We assessed the
effect of SESScore ™ on cost of care while controlling for other patient characteristics, 
and then examined the extent to which disparities in cost of care could be attributed 
to differences in hospital factors. Fixed effect models were used. RESULTS: SESScore 
™ was a signiﬁ cant predictor of cost of care for major orthopedic surgery. Comparing 
the lowest quintile of SESScore ™ to the highest, the cost difference was positive and 
signiﬁ cant (p  0.000). After further adjustment for hospital factors, the difference
was reduced. Within hospitals, there were only small differences in adjusted cost of 
care by patients’ socioeconomic status. CONCLUSIONS: When undergoing major 
orthopedic surgery, patients with a lower socioeconomic status have higher rates of 
cost of care than patients with a higher socioeconomic status, despite similar insurance 
coverage provided by Medicare.
PHC3
COST-EFFECTIVENESS ANALYSIS OF PIMOBENDAN COMPARED TO 
BENAZEPRIL FOR THE TREATMENT OF ACQUIRED MYXOMATOUS 
MITRAL VALVE DISEASE IN DOGS IN GERMANY
Poulsen Nautrup B1, Poulsen Nautrup C2, Van Vlaenderen I3
1EAH Consulting, Juelich, Juelich, Northrhine Westf, Germany, 2Ludwig-Maximilians University 
Munich, Munich, Bavaria, Germany, 3Deloitte, Diegem, Diegem, Belgium
OBJECTIVES: Myxomatous mitral valve disease (MMVD) presents a frequent heart 
problem in dogs. The inodilator pimobendan has shown to increase survival time of 
affected dogs when compared to the ACE inhibitor benazepril. The objective of this 
study was to estimate the cost-effectiveness of pimobendan compared to generic
benazepril for treatment of MMVD in dogs in Germany. METHODS: A Markov 
model was developed to calculate costs and beneﬁ ts of pimobendan and benazepril
over a 1-year time horizon in dogs with MMVD on concurrent furosemide treatment. 
The model structure allowed for a differentiation in costs and transition probabilities
between treatment start and maintenance treatment, and included the health states 
asymptomatic MMVD, symptomatic MMVD, treatment failure, euthanasia, and
sudden death. Most transition probabilities were based on randomized controlled
trials. Input-data on treatment pattern were derived from published literature, and
cost data taken from ofﬁ cial price and tariff lists (year 2008, perspective of the dog 
owner). Missing data were obtained from experts in canine cardiology. RESULTS:
Over the 1-year time horizon, mean total therapy cost per dog on pimobendan was 
€463.55 versus € 284.29 for benazepril. Mean survival was 274 days and 129 days
for dogs on pimobendan and benazepril, respectively; resulting in a cost of € 1.24 for 
each additional day of life on pimobendan. Mean costs per treatment day were lower 
with pimobendan (€ 1.69) when compared to benazepril (€ 2.20). Extensive one-way
and probabilistic sensitivity analyses conﬁ rmed the robustness of the results. CON-
CLUSIONS: Pimobendan is a cost-effective treatment of MMVD if the dog owner is
willing to pay a price below the normal range of food costs in Germany for each 
additional day of life. Lower total treatment costs for benazepril are merely attributed 
to a shorter survival, as pimobendan resulted in less costs per treatment day compared
to benazepril.
PHC4
COST-EFFECTIVENESS OF PIMOBENDAN VERSUS BENAZEPRIL IN 
ACQUIRED MYXOMATOUS MITRAL VALVE DISEASE IN DOGS: 
AN ADAPTATION TO SWITZERLAND
Poulsen Nautrup B1, Van Vlaenderen I2
1EAH Consulting, Juelich, Juelich, Northrhine Westf, Germany, 2Deloitte, Diegem, Diegem, 
Belgium
OBJECTIVES: Myxomatous mitral valve disease (MMVD) presents a frequent heart 
problem in dogs. The objective of this study was to estimate the cost-effectiveness of 
pimobendan compared to benazepril for treatment of MMVD in dogs in Switzerland.
METHODS: A Markov model including the health states asymptomatic MMVD, 
symptomatic MMVD, treatment failure, euthanasia, and sudden death, was adapted 
to Switzerland. Costs (year 2008, perspective of the dog owner) and beneﬁ ts (life days 
gained, time without symptoms of heart failure) were calculated over a 1-year time
horizon for dogs on pimobendan or benazepril respectively, both on concurrent furo-
semide treatment. Most transition probabilities were based on randomized controlled 
trials. Missing data and input-data on treatment pattern were obtained from experts 
in canine cardiology. RESULTS: Mean survival over the 1-year time horizon was 274 
days for dogs on pimobendan versus 129 days for dogs on benazepril. Time spent
without any symptoms of heart failure was 86 days for pimobendan versus 15 days
for benazepril. Mean total therapy cost per dog on pimobendan was CHF 905.68
versus CHF 546.52 for benazepril; resulting in a cost of CHF 2.48 for each additional
day of life on pimobendan. Mean costs per treatment day were lower with pimoben-
dan (CHF 3.31) compared to benazepril (CHF 4.24). Extensive one-way and proba-
bilistic sensitivity analyses conﬁ rmed the robustness of the results. CONCLUSIONS:
Pimobendan is a cost-effective treatment of MMVD if the dog owner is willing to pay
a price within the normal range of food costs for each additional day of life. The 
results indicate a better quality of life of dogs on pimobendan, as they spent substan-
tially more time without any symptoms of heart failure compared to dogs on benaz-
epril. Lower total treatment costs for benazepril are merely attributed to a shorter 
survival, as pimobendan resulted in less costs per treatment day.
PHC5
CHOICE OF HEMOSTATIC AGENT AND HOSPITAL LENGTH
OF STAY IN CARDIOVASCULAR SURGERY
Krishnan S1, Conner TM2, Leslie RC2, Stemkowski S3
1Baxter BioSurgery, Westlake Village, CA, USA, 2Outcomes Research Consulting, Austin, TX, 
USA, 3Premier Inc, Charlotte, NC, USA
OBJECTIVES: Hemostatic agents (HAs) are efﬁ cacious in reducing blood loss during
surgery, which may impact post-operative health care utilization and length of stay 
(LOS). The purpose of this study was to compare expected and actual LOS by choice
of HA in cardiac procedures. METHODS: Hospital data were extracted from a large 
U.S. hospital-based, service-level comparative database. Procedures conducted between 
2003 and 2006 were identiﬁ ed using principal ICD-9 codes and limited by Diagnostic
Related Groups (DRGs). Four cohorts for comparison were Floseal, Surgicelthrombin, 
Gelfoamthrombin, and other. Expected LOS was derived using 2006 Centers for
Medicare and Medicaid (CMS) geometric mean LOS by DRG and two-part regression
models were created to assess outcome. RESULTS: A total of 36,950 discharges were 
included. Floseal use was associated with signiﬁ cantly less likelihood of exceeding the 
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expected LOS compared to baseline (OR  0.791, p  0.01). Among patients who did 
exceed the expected LOS, Floseal patients did so at a reduced rate (IRR  0.891, p 
0.01). Surgical use was not associated with any signiﬁ cant difference from baseline, 
while Gelfoam use showed a slightly higher associated likelihood of exceeding
expected LOS (OR  1.099, p  0.05). CONCLUSIONS: Floseal use was associated
with lower than expected LOS in cardiac surgery. Given small proﬁ t margins achieved 
by hospitals today, further assessment is warranted to distinguish products with favor-
able outcomes.
HEALTH CARE INTERVENTIONS – Patient-Reported Outcomes Studies
PHC6
SUBJECTS SUFFERING FROM HALITOSIS: IMPACTS OF THE TREATMENT
Taieb C
Pierre Fabre, Boulogne, France
OBJECTIVES: Assess the impact in terms of quality of life 9QoL) of ALIBI (Extract 
of green tea & Parsley essential oil) in patients suffering from halitosis. METHODS:
An observational, longitudinal and prospective assessment, carried out in a pharmacy 
on subjects suffering from halitosis who were seeking an immediate remedy. The 
questionnaire used was the Halitosis Quality of Life Questionnaire (HQLQ), the only 
validated questionnaire regarding halitosis. RESULTS: A total of 311 subjects suffer-
ing from halitosis were included. The average age was 45.07 o 15.99 years. The sex 
ratio was 29.90% of men vs 70.10% of women. Also, 71.06% of the subjects exer-
cised a professional activity. Seventy percent claimed they brushed their teeth after
each meal; 44.23 of the subjects used accessories (26% inter-dental toothbrushes, 29%
dental ﬂ oss and 11% tongue scrapers). Sixty-six percent stated they became aware of 
halitosis themselves, 30% from a third party. Halitosis had been present for approxi-
mately 5 years; 11% had consulted only their halitosis. The overall HQ22 score was 
14.68 o 7.86, after 7 days of treatment by Extract of green tea & Parsley essential 
oil, the score was 10.23 o 8.00. The improvement was statistically signiﬁ cant (p 
0.001). The evolution of each of the 4 dimensions (“daily life”, “mental”, “emo-
tional”, “social and work”) also improved. The everyday life score changed from 2.95
o 2.10 to 1.89 o 1.92, the Emotional score changed from 2.46 o 2.10 to 1.81 o 1.95,
the Mental score changed from 4.45 o 2.75 to 3.22 o 2.80 and the Social & Work 
dimension score changed from 4.92 o 2.50 to 3.54 o 2.60 CONCLUSIONS: Since
using Extract of green tea & Parsley essential oil, 90% of subjects suffering from hali-
tosis have experienced an improvement in their everyday lives, 83% feel more at ease 
in their cultural and social activities. These results conﬁ rm the improvement of QoL 
among subjects suffering from halitosis after 7 days of treatment.
PHC7
DEVELOPMENT AND VALIDATION OF SPECIFIC HEALTH RELATED 
QUALITY OF LIFE QUESTIONNAIRE FOR HALITOSIS: THE HALITOSIS
QUALITY OF LIFE QUESTIONNAIRE (HQLQ)
Taieb C1, Maso H2
1Pierre Fabre, Boulogne, France, 2PFOC, CASTRES, France
OBJECTIVES: Halitosis or bad breath is a chronic condition affecting a large fraction 
of the adult population. The aim of this study was to develop and validate a halitosis-
speciﬁ c quality of life questionnaire for adults. METHODS: Development and valida-
tion of the questionnaire have been performed using the standardized multi-step
method. RESULTS: A total of 169 eligible patients answered both questionnaires at
day 0. Sixty-three did the same a second time at day 7. The initial pool of questions 
comprised 24 items. Two items were deleted, the ﬁ rst was considered redundant and 
the due to ceiling effect, i.e., a ceiling effect means that most patients are not worried 
by a particular item. This resulted in a questionnaire of 22 items. Eleven items were 
allocated to each of the two domains. None of the items allocated to a domain showed 
a signiﬁ cantly higher correlation with the total score of the other domain. CONCLU-
SIONS: The ﬁ nal version of the HQLQ contains 22 items covering 2 domains of 
quality of life assessment, namely “social and daily life activities” and “personal
domain.” The questionnaire is designed for self-administration. It showed both good
reliability and construct validity. The intraclass correlation indicates good responsive-
ness of the HQLQ. To be valid, a questionnaire needs to be easily understood and 
completed by the population concerned. In summary, the health-related Quality of 
Life Questionnaire for halitosis is a valid instrument for use in adults complaining of 
bad breath. It is the ﬁ rst ever to have been developed with this speciﬁ c aim.
HEALTH CARE INTERVENTIONS – Health Care Use & Policy Studies
PHC8
REGIONAL DISPARITIES AND ECONOMIC OUTCOMES ASSOCIATED
WITH MINIMALLY INVASIVE AND CONVENTIONAL SURGERIES OF THE
CHEST, ABDOMEN, AND PELVIS
Moore M1, Hochheiser L2, Gunnarsson C3, Ladapo J4, Borah B5
1Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA, 2University of Vermont, Jackson, WY, USA, 
3S2 Statistical Solutions, Inc, Cincinnati, OH, USA, 4Beth Israel Deaconess Medical Center, 
Boston, MA, USA, 5i3 Innovus, Eden Prairie, MN, USA
OBJECTIVES: Rising health care expenditures remains a major policy concern. 
Research suggests that regional variations in spending contribute to this crisis.
Regional variations in the utilization of minimally invasive and conventional
approaches to common surgeries is an extension of this paradigm, and likely con-
tributes to disparities in health outcomes and expenditures across the nation. This
study examines these factors through the lens of the following procedures: colectomy, 
laparoscopic and vaginal hysterectomy, esophagogastric fundoplasty, cholecystectomy, 
appendectomy, bariatric surgery, breast biopsy, ventral hernia repair, and lung reduc-
tion surgery. METHODS: We performed a retrospective cohort analysis using 
medical and pharmacy claims data from a large national health plan. Data on patient
age, geographic residence, and severity were extracted. Geographic regions were cat-
egorized as West, Midwest, Northeast and South. Outcomes of interest included 
intraoperative and post-operative complications, length of hospital stay, infection rates 
and associated antibiotic utilization, and readmission rates. Total expenditures for
health care utilization directly associated with a patient’s surgery were estimated.
Generalized linear models were constructed using a gamma distribution and log link 
function to estimate the effect of surgical approach on major outcomes while adjusting 
for other factors. RESULTS: Regional variations in utilization of laparoscopic and
open surgeries are most pronounced for colectomy, hysterectomy, and bariatric
surgery. Smaller but still signiﬁ cant variations in the utilization of minimally invasive 
and conventional esophagogastric fundoplasty, appendectomy, and breast biopsy were 
also observed. Colectomy, vaginal hysterectomy, esophagogastric fundoplasty, chole-
cystectomy, appendectomy, breast biopsy, and lung reduction surgery were associated 
with lower follow-up health care expenditures when a minimally invasive route was 
used. CONCLUSIONS: Signiﬁ cant regional variations in the utilization of minimally
invasive and conventional approaches to common surgeries exist in the United States.
To the extent that, surgical approach impacts infection risk, complications, length of 
stay, and other metrics, these variations contribute to disparities in health outcomes
and expenditures.
MUSCULAR-SKELETAL DISORDERS – Clinical Outcomes Studies
PMS1
INCREASED STANDARDIZED MORTALITY RATIO IN WORKERS WITH 
PERMANENT OCCUPATIONAL DISABILITY OF LOWER LIMB: 
A FOLLOW-UP STUDY OF 21 YEARS
Lin SH1, Lee HY1, Chang YY1, Jang Y1, Chen PC1, Wang JD2
1National Taiwan University Hospital, Taipei, Taiwan, 2National Taiwan University, College of 
Public Health, Taipei, Taiwan
OBJECTIVES: This study intends to determine if there is increased mortality for dif-
ferent causes among workers with permanent lower limb occupational disability. 
METHODS: We collected all cases of permanent occupational disability from the 
database of compensation claim of Bureau of Labor Insurance between 1986 and 
2006, which were linked with the national mortality registry to obtain the person-
years at risk for different calendar periods. The standardized mortality ratios (SMR) 
for workers with permanent disability of upper and lower limbs were calculated to
estimate the risk of mortality due to different causes in comparison with the general 
population of Taiwan. The software package of LTAS established by the National
Institute of Occupational Safety and Health of the United States was employed for
the above calculation. RESULTS: We found signiﬁ cantly higher SMR in the following 
causes of death for workers sustained a permanent occupational disability : Gastroin-
testinal cancers (SMR  1.28, 95% conﬁ dence interval (CI)  1.021.59), benign 
tumor(SMR  7.38, 95% CI  3.1914.54), diabetes mellitus (SMR  2.55, 95% 
CI  1.923.31), hypertension and stroke (SMR  1.42, 95% CI  1.06 1.86), suicide 
(SMR  1.92, 95% CI  1.192.93), injury (SMR  1.88, 95% CI  1.222.78), 
respiratory diseases (SMR  2.09, 95% CI  1.542.78), the digestive system diseases 
(SMR  1.36, 95% CI  1.021.77), and chronic kidney diseases (SMR  2.48, 95% 
CI  1.473.92). Workers suffering from permanent disability of upper limbs only
showed an increased SMR for digestive system. CONCLUSIONS: Workers with per-
manent lower limb occupational disability have higher risks of digestive cancer, injury, 
suicides, diabetes, and vascular diseases, which might be related to a general lack of 
exercise and should be considered in the process of rehabilitation and/or health promo-
tion for these populations.
PMS2
GOUT AND THE RISK OF ACUTE MYOCARDIAL INFARCTION AMONG
ELDERLY WOMEN
De Vera MA1, Rahman MM2, Bhole V2, Rankin J2, Aghajanian J2, Kopec J2, Choi HK1
1UBC School of Population & Public Health, Vancouver, BC, Canada, 2Arthritis Research
Centre of Canada, Vancouver, BC, Canada
OBJECTIVES: Gout is a common inﬂ ammatory arthritis associated with hyperurice-
mia. Despite the substantial prevalence of gout among ageing women, little is known 
about associated cardiovascular risks in this population. Previous studies that have 
shown an association between gout and acute myocardial infarction (AMI) have been
limited to men. Our objective was to evaluate the association between gout and non-
fatal AMI among elderly women, aged q65 years, and compare ﬁ ndings in men. 
METHODS: We conducted a case control study nested within a population-based 
gout cohort in the British Columbia Linked Health Database. Over a 12-year follow-
up, we identiﬁ ed incident cases of nonfatal AMI from hospitalization data and 
matched with 5 controls according to age, gender, and length of medical record. Deﬁ ni-
tions of exposure and outcome were physician-entered ICD-9 codes. Conditional 
logistic regression models were used to estimate the association between gout and AMI 
